Lin T Y, Lee C S, Chen K M, Chen C C
Department of Surgery, National Taiwan University Hospital, Taipei, Republic of China.
Br J Surg. 1987 Sep;74(9):839-42. doi: 10.1002/bjs.1800740931.
During the 31 year period 1954 to 1985, 225 major hepatic resections have been performed for symptomatic primary carcinoma of the liver, of which right hepatic lobectomy was performed in 115, extended right hepatic lobectomy in 11, trisegmentectomy in 2, left hepatic lobectomy in 94, and middle hepatectomy in 3. In addition there were 107 partial hepatic resections for 89 asymptomatic small hepatocellular carcinomas. In the 225 patients undergoing major hepatic resection, the operative mortality was 8.0 per cent. In the 107 patients undergoing partial hepatic resection, the operative mortality was 5.6 per cent. Of the total of 314 hepatic resections for primary carcinoma of the liver, 309 were undertaken for hepatocellular carcinoma and the remaining 5 were carried out for cholangiocarcinoma. All hepatic resections in this series were performed with the finger fracture technique without controlling the hepatic hilar vessels, hepatic ducts or hepatic veins outside the liver, although hepatic clamping and the Pringle manoeuvre were also used in selective cases. Of 207 cases who survived major hepatic resection, 119 cases died within one year after the operation, mainly due to recurrence of cancer in the remaining residual lobe, lung metastasis or late hepatic failure. The 5 year survival rate is 18.0 per cent, 12 patients are still alive and well after more than 5 years and the longest survival is 23 years. Of the 89 patients with small asymptomatic hepatocellular carcinomas, 28 died within one to four years of surgery because of a second new growth.
在1954年至1985年的31年期间,因有症状的原发性肝癌进行了225例主要肝切除术,其中右肝叶切除术115例,扩大右肝叶切除术11例,三段切除术2例,左肝叶切除术94例,中肝切除术3例。此外,对89例无症状小肝细胞癌进行了107例部分肝切除术。在225例行主要肝切除术的患者中,手术死亡率为8.0%。在107例行部分肝切除术的患者中,手术死亡率为5.6%。在总共314例原发性肝癌肝切除术中,309例为肝细胞癌,其余5例为胆管癌。本系列所有肝切除术均采用手指骨折技术,未在肝外控制肝门血管、肝管或肝静脉,尽管在选择性病例中也使用了肝门阻断和普林格尔手法。在207例主要肝切除术后存活的患者中,119例在术后一年内死亡,主要原因是剩余残叶癌症复发、肺转移或晚期肝功能衰竭。5年生存率为18.0%,12例患者在5年以上仍存活且状况良好,最长存活时间为23年。在89例无症状小肝细胞癌患者中,28例在手术后1至4年内因出现第二个新肿瘤而死亡。